hinlab

Excited to represent hinlab at the eWEAR Health Prize Finals at Stanford University! 🗓 Date: Friday, November 8, 2024 ⏰ Time: 1:00 pm – 5:00 pm PST (in-person only) 📍 Location: McCaw Hall, Frances C. Arrillaga Alumni Center, Stanford University (326 Galvez St, Stanford, CA 94305) Looking forward to connecting with everyone there! Link: https://lnkd.in/eS9UMmMF Stanford Wearable Electronics Initiative (eWEAR)

Attend the premier Deep Tech pitch competition at Stanford on 11/8. Eight start-ups in med/health + AI compete for $50,000 prize. Network with top investors and young entrepreneurs. View Demo Showcase of innovations. Meet co-founder of Verily, Jessica Mega. Register: https://lnkd.in/gw5sR5g8 Adaptyx Biosciences | continuous biomonitoring of small molecules and proteins  Apricity Robotics | AI trained robotic ultrasound imaging Nuroo | earpods for assessing emotional states hinlab | wearable remote cardiac monitoring SculptAR | real-time fusion of 3D images into AR overlays on patients for surgeons Sonologi | continuous wearable ultrasound imaging Swaza | oxygenation nanoparticle therapeutic Vitaly Medical | wearable on wrist for early detection of stroke Jessica Mega Apricity Robotics hinlab Swaza Vitaly Medical Trishia Chemaly Kathrin Gerpheide Denys-Michel de Larouzière Suoyi Feng Sonologi, Inc. Artem A. Trotsyuk Chonghe Wang Alex Yoshikawa Aaron Crookes DAO Nobel Erik Finman Paul Drzaic Lu Zhang Pankaj Kedia Zhenan Bao Xiang Qian #wearables #wearabletech #AI #medtech #healthtech #startups #bioscience #robotics #XR Stanford Founders #biosensors #ultrasound #EEG

Excited to be pitching hinlab and to be among the eight finalist companies in Med/Health + AI, selected for Stanford University’s premier Deep Tech competition on November 8th! 🩺 🚀 Stanford University - Stanford Wearable Electronics Initiative (eWEAR)

In September, I had the opportunity to present our vision for the future of cardiology on stage at the LSI conference in Sintra, Portugal. I wanted to share some thoughts after this event. The LSI conference is one of the few events that focuses entirely on medical technologies. It’s a fantastic chance to connect with hundreds of entrepreneurs, investors, and industry experts. The format, which includes numerous one-on-one meetings, makes it a must-attend event for anyone involved in the healthcare field. You can meet entrepreneurs and investors from around the world, as well as executives from leading medical companies. Another highlight was seeing the wide variety of projects, from AI software to miniaturized MRI machines, surgical robots, potassium measurement patches, and many more, all aimed at a common goal: saving lives and improving healthcare systems. It was inspiring to witness such innovation and the shared purpose among everyone involved. I was particularly interested in Alan Cohen’s talk from DCVC, where he presented the TechMed thesis. Unlike traditional medtech companies that mainly create new medical devices, TechMed companies distinguish themselves by developing smart software systems that enhance medical techniques. By integrating advanced technologies like AI, machine learning, and computer vision with devices, TechMed companies are setting themselves apart in the industry. At hinlab, we fully support this TechMed vision, and I was excited to share our progress in building the most advanced AI-augmented solution in the field of cardiology! #LSI ##TechMed #Healthcare #Healthtech #Medtech #Wearables #AI #Cardiology

hinlab (LSI Europe ‘24 Innovator) is a health technology company developing the most advanced AI-augmented device in cardiology, with a mission to transform how cardiac diagnosis and care are delivered. Hinlab is headquartered in the U.S., and has a R&D office in Paris. The company develops wearable devices that continuously monitor vital signs such as blood pressure and heart rate, with a focus on transferring this data seamlessly into medical records. Their products use AI-driven algorithms to detect early signs of deterioration in patients, helping healthcare professionals intervene before conditions worsen. Hinlab's goal is to improve patient care, reduce healthcare costs, and prevent avoidable deaths by providing real-time, data-driven insights through unobtrusive monitoring devices. Hinlab has already completed its first FDA submission, obtained ISO 13485 certification, and successfully passed the clinical validation studies relevant to its 510(k) certification. We’re excited to announce that Co-Founder & CEO, Denys-Michel de Larouzière has been selected to present hinlab at LSI Europe ‘24 this September 16-20th in Sintra, Portugal. Join us in Portugal to meet with Denys-Michel and learn more about hinlab.